These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1661630)

  • 21. Hypnotherapy for children with functional abdominal pain or irritable bowel syndrome: a randomized controlled trial.
    Vlieger AM; Menko-Frankenhuis C; Wolfkamp SC; Tromp E; Benninga MA
    Gastroenterology; 2007 Nov; 133(5):1430-6. PubMed ID: 17919634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of irritable bowel syndrome. A case control experience.
    Astegiano M; Pellicano R; Terzi E; Simondi D; Rizzetto M
    Minerva Gastroenterol Dietol; 2006 Dec; 52(4):359-63. PubMed ID: 17108865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sensation of bloating and visible abdominal distension in patients with irritable bowel syndrome.
    Chang L; Lee OY; Naliboff B; Schmulson M; Mayer EA
    Am J Gastroenterol; 2001 Dec; 96(12):3341-7. PubMed ID: 11774947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of irritable bowel syndrome.
    Rock L; Nasrallah SM
    Compr Ther; 1984 Dec; 10(12):18-23. PubMed ID: 6097397
    [No Abstract]   [Full Text] [Related]  

  • 25. Review article: clinical evidence to support current therapies of irritable bowel syndrome.
    Camilleri M
    Aliment Pharmacol Ther; 1999 May; 13 Suppl 2():48-53. PubMed ID: 10429740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of partially hydrolyzed guar gum in the treatment of irritable bowel syndrome.
    Giannini EG; Mansi C; Dulbecco P; Savarino V
    Nutrition; 2006 Mar; 22(3):334-42. PubMed ID: 16413751
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Irritable bowel syndrome.
    Spinelli A
    Clin Drug Investig; 2007; 27(1):15-33. PubMed ID: 17177577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial.
    Ducrotte P; Dapoigny M; Bonaz B; Siproudhis L
    Aliment Pharmacol Ther; 2005 Feb; 21(4):435-44. PubMed ID: 15709995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Otilonium bromide enhances sensory thresholds of volume and pressure in patients with irritable bowel syndrome.
    Czimmer J; Süto G; Király A; Mózsik G
    J Physiol Paris; 2001; 95(1-6):153-6. PubMed ID: 11595430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Otilonium bromide: a selective spasmolytic for the gastrointestinal tract.
    Evangelista S
    J Int Med Res; 1999; 27(5):207-22. PubMed ID: 10689627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Irritable bowel syndrome. Practical management.
    Talley NJ
    Aust Fam Physician; 2000 Sep; 29(9):823-8. PubMed ID: 11008383
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Irritable colon syndrome: therapeutic activity of otilonium bromide alone or in combination with benzodiazepine. Controlled double-blind study].
    Tarquini M; Sannino L; Bazuro G; Palomba M; Ricci C; Koch M; Fracasso P; Capurso L
    Clin Ter; 1984 Jun; 109(6):525-31. PubMed ID: 6236943
    [No Abstract]   [Full Text] [Related]  

  • 33. Quaternary ammonium derivatives as spasmolytics for irritable bowel syndrome.
    Evangelista S
    Curr Pharm Des; 2004; 10(28):3561-8. PubMed ID: 15579053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bran and irritable bowel syndrome: the primary-care perspective.
    Miller V; Lea R; Agrawal A; Whorwell PJ
    Dig Liver Dis; 2006 Oct; 38(10):737-40. PubMed ID: 16880013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improvement in irritable bowel syndrome following ano-rectal surgery.
    Palmer BV; Lockley WJ; Palmer RB; Kulinskaya E
    Int J Colorectal Dis; 2002 Nov; 17(6):402-11. PubMed ID: 12355216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Irritable bowel syndrome.
    Chin D; Milhorn HT; Robbins JG
    J Fam Pract; 1985 Feb; 20(2):125-7, 131, 135-6 passim. PubMed ID: 2981955
    [No Abstract]   [Full Text] [Related]  

  • 37. Carbohydrate malabsorption and the effect of dietary restriction on symptoms of irritable bowel syndrome and functional bowel complaints.
    Goldstein R; Braverman D; Stankiewicz H
    Isr Med Assoc J; 2000 Aug; 2(8):583-7. PubMed ID: 10979349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A controlled, randomized, double-blind trial to evaluate the effect of a supplement of cocoa husk that is rich in dietary fiber on colonic transit in constipated pediatric patients.
    Castillejo G; Bulló M; Anguera A; Escribano J; Salas-Salvadó J
    Pediatrics; 2006 Sep; 118(3):e641-8. PubMed ID: 16950955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IBS and the role of otilonium bromide.
    Boeckxstaens G; Corazziari ES; Mearin F; Tack J
    Int J Colorectal Dis; 2013 Mar; 28(3):295-304. PubMed ID: 23178991
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical and instrumental evaluation by multiple colonic manometry of tiropramide, trimebutine and octylonium bromide in irritable colon. II. Repeated oral administration].
    Galeone M; Benazzi E; Bossi M; Moise G; Riva A; Stock F
    Pharmatherapeutica; 1986; 4(8):496-509. PubMed ID: 3714757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.